Recruiting

CellCore Protocols

Sponsor:

OvationLab

Code:

NCT07753798

Conditions

Environmental Toxins

General Health

Eligibility Criteria

Sex: All

Age: 25 - 65

Healthy Volunteers: Not accepted

Interventions

CellCore Foundational Protocol

CellCore - BioToxin Binder & Drainage Activator

Study Details

Brief summary:

The primary purpose of this study is to evaluate the effects of CellCore protocols on environmental toxicant biomarkers among adult patients with high baseline toxicant levels. Patients will be allocated to one of two CellCore protocols (Foundational Protocol or BioToxin Binder/Drainage Activator) based on overall physical health, mental health, and fatigue levels at baseline.

A prospective, practitioner-led, open-label, single-arm intervention with the CellCore protocols will be conducted to measure pre- and post-intervention changes in urinary environmental toxicant biomarkers and validated, patient-reported health outcomes.

Conditions

Environmental Toxins

General Health

Study ID

NCT07753798

Start date

Sep 28, 2026

Status verified date

Oct, 2026

Completion date

Jun, 2027

Anticipated

Primary completion date

Jun, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 25 - 65

Healthy Volunteers: Not accepted

Inclusion Criteria:

1. Adult between 25 and 65 years of age
2. Documented elevated urinary environmental toxicant levels above the 75th percentile of at least 5 toxins on baseline environmental toxin test
3. PROMIS - Global Health - Physical Health t-scores < 42.4 for Foundational Protocol (otherwise BioToxin Binder/Drainage Activator Protocol)
4. Currently receiving care from a qualified, participating practitioner
5. Lives in the United States
6. Ability to speak and read English
7. Willing and able to follow the assigned CellCore protocols and complete all required testing and questionnaires
8. Willing and able to provide informed consent

Exclusion Criteria:

1. Currently undergoing active chelation therapy
2. Participation in a structured detoxification program within the prior 60 days, including use of activated charcoal, bentonite/zeolite clay, chlorella, cholestyramine
3. Ongoing occupational toxic exposure (e.g., working on golf course, dry cleaning facility) that cannot be reduced or controlled during the study period
4. Pregnancy or lactation, or planning pregnancy during the study period
5. Major comorbid medical condition requiring complex specialty management that, in the practitioners' clinical judgment, would interfere with safe study participation
6. Anticipated initiation of additional detoxification products, major dietary changes, or other significant co-interventions during the study period
7. Unable or unwilling to provide informed consent

Study Design

Enrollment

40 participants

Anticipated

Allocation

Non randomized

Intervention Model

Parallel Assignment

Primary purpose

Other

Interventions and Outcome Measures

Arms

experimental: CellCore - Foundational Protocol

experimental: CellCore - BioToxin Binder + Drainage Activator

Interventions

CellCore Foundational Protocol

The CellCore Foundational Protocol is a four-phase, four-month supplement program designed to support drainage, gut and immune balance, whole-body immune support, and systemic detoxification in a stepwise sequence.

CellCore - BioToxin Binder & Drainage Activator

BioToxin Binder is a first-step detox support supplement that uses CellCore BioActive Carbon® carbon technology to bind biotoxins while supporting gut microbiome balance, immunity, digestive function, cellular repair, and energy production. Drainage Activator is a drainage-support supplement aimed at the extracellular matrix and lymphatic drainage, using herbs and mushrooms to help open drainage pathways and support the body's natural detox processes. This is a three-month combination protocol.

Primary outcome measure

  • Mosaic Envirotox Burden + Heavy Metals Urinary Panel [ Time Frame: Measured at baseline, one month, and end of protocol (4 months for Foundational Protocol & 3 months for BioToxin Binder + Drainage Activator protocol) ]

Central Contacts and Locations

Central contacts

Locations

OvationLab

Recruiting

Richmond, Virginia, United States, 23220

Contacts

More Information

Sponsor

OvationLab

Last update posted

Oct 19, 2026

Last verified

Oct, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-10-20. This information was provided to ClinicalTrials.gov by OvationLab on 2026-10-19. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.